Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Biochemical/growth characteristics of S. maltophilia .

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Starch

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Various niches in environment and clinical settings as reservoir for S. maltophilia and unique attributes.

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques:

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: S. maltophili a: (A) Infected digital ulcer of the second and third fingers of the right hand (Trignano et al., ); (B) Small colonies (indicated by red dashed circle) and big colonies cultivated on agar plates containing high concentrations of ampicillin (600 μg/mL) (Abda et al., ); (C) Characterization of flagella Produced by Clinical Strains of S. maltophilia by scanning electron microscope (de Oliveira-Garcia et al., ); (D) Scanning electron micrograph of a S. maltophilia biofilm grown at 30°C for 24 h in a flow cell (Briandet et al., ); (E) Transmission electron microscopy images of Vermamoeba vermiformis infected by S. maltophilia (Cateau et al., ); (F) Colored transmission electron micrograph (TEM) of S. maltophilia (Science Photo Library).

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Infection, Produced, Microscopy, Transmission Assay, Electron Microscopy

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Virulence and virulence associated factors in S. maltophilia and its potential application in diagnosis/therapy.

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Biomarker Discovery, Blocking Assay, Sequencing, Bacteria, Agglutination, Variant Assay

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Zone diameter and Minimal Inhibitory Concentration (MIC) interpretive standards for Stenotrophomonas maltophilia (M100-S24, Clinical and Laboratory Standards Institute, 2014 ).

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Concentration Assay

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Multiple antibiotic resistant profile of S. maltophilia from root rhizosphere (Adegoke and Okoh, ).

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques:

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Some of the resistance genes acquired/reserved in S. maltophilia .

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Expressing

Journal: Frontiers in Microbiology

Article Title: Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

doi: 10.3389/fmicb.2017.02276

Figure Lengend Snippet: Some phages for potential treatment of multiple antibiotic resistant S. maltophilia .

Article Snippet: Standards “zone diameter and minimal inhibitory concentration (MIC) interpretive Standards' for S. maltophilia” as approved by Clinical and Laboratory Standards Institute ( ) is depicted in Table .

Techniques: Electron Microscopy, Sequencing, Environmental Sampling

Journal: Cureus

Article Title: Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study

doi: 10.7759/cureus.23263

Figure Lengend Snippet: Calculated by applying the Clinical and Laboratory Standards Institute (CLSI) break-point values for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin; and broth dilution MIC breakpoints for ceftazidime. There are no MIC interpretive criteria for tigecycline, colistin, or aztreonam, so susceptibility to them is assumed using interpretive criteria for Enterobacteriaceae. European Committee on Antimicrobial Susceptibility Testing (EUCAST) has only published breakpoint criteria for trimethoprim-sulfamethoxazole. Total number of samples, n = 317

Article Snippet: The US Clinical and Laboratory Standards Institute (CSLI) has published disc-diffusion minimal inhibitory concentration (MIC) breakpoints for trimethoprim-sulfamethoxazole, minocycline, and levofloxacin and broth dilution MIC breakpoints for ticarcillin-clavulanic acid, ceftazidime, minocycline, levofloxacin, and chloramphenicol [ ].

Techniques: